UK Launches New Weight-Loss Pill

Eli Lilly has introduced its weight-management and type 2 diabetes pill, Foundayo, in the UK, making Britain the first country in Europe where the oral treatment is available.

Key points

• In the US, self-pay rates for the Wegovy pill and Foundayo start at $149 per month and can rise to $299 and $349 respectively for higher doses.
• Before the treatment can be created available on the state-run National Health Service, England's cost-effectiveness watchdog, the National Institute for Health and Care Excellence, must assess it.
• Lilly remarked the pill will probable be priced between £100 and £120, lower than the company's Mounjaro injection.
• Add ProPakistani to Preferred Sources and see more of our stories in Google Search and Top Stories.
• Royal Cosmetic Surgery Clinic Launches Advanced Laparoscopic Surgery Tower.

For context, the pill, known chemically as orforglipron, will be available through private prescription after Britain's medicines regulator authorised it on August 10.

It is the second GLP-1 tablet to be introduced in the UK after Novo Nordisk's Wegovy pill.

Before the treatment can be created available on the state-run National Health Service, England's cost-effectiveness watchdog, the National Institute for Health and Care Excellence, must assess it. Action Ordered Against HIV Outbreak at Karachi Hospital.

Lilly remarked it is working with NICE during the agency's review of Foundayo for weight-management access.

For context, a NICE spokesperson remarked the agency has asked for more information after its first committee gathering and has not set a date for a second review.

In practice, the spokesperson additionally stated Novo has not yet submitted evidence for the Wegovy pill.

Until the review process is completed, patients can access Foundayo through private providers.

Lilly remarked the pill will probable be priced between £100 and £120, lower than the company's Mounjaro injection. It costs £330 for a month's supply.

Private providers in the UK at present rate the Wegovy weight-loss pill from £74 to £129 per month for initial low doses, with rates rising as patients move to higher doses. Royal Cosmetic Surgery Clinic Launches Advanced Laparoscopic Surgery Tower.

Meanwhile, a new US Medicare pilot additionally offers selective access to the oral drugs for $50 a month.

While Novo's Wegovy pill has received a positive recommendation from the European Medicines Agency, with a final decision from the European Commission still pending, foundayo remains under review in the European Union. Stay Connected with ProPakistani. Obtain the latest international news and global stories wherever you prefer. Follow on Google Discover.

Add as a preferredSource on Google Follow on Google News Join WhatsApp.

Taken together, the developments around UK Launches New Weight point to a situation that is still moving, and the coming days should bring more clarity.